Cardima’s Revelation: AF Self-Monitoring, Hazy Endpoints Hamper Review

The ability of self-reporting to accurately track reduction in atrial fibrillation burden is cast into doubt by FDA panel experience with Cardima's Revelation ablation system data submission

More from Archive

More from Medtech Insight